FDA Inspection 1232702 - GlaxoSmithKline Biologicals - March 12, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GlaxoSmithKline Biologicals

Record Details

This FDA Inspection record concerns GlaxoSmithKline Biologicals, with an inspection on March 12, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: GlaxoSmithKline Biologicals
Inspection Date: March 12, 2024
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 70a6a284-2119-4f02-9b73-85f02c66c432

Violation Codes3

21 CFR 211.170(b)21 CFR 211.19221 CFR 211.67(b)(6)

Full citation text and observation details available on the Dashboard.